193 related articles for article (PubMed ID: 25056087)
1. Ovarian responsiveness in women receiving fertility treatment after methotrexate for ectopic pregnancy: a systematic review and meta-analysis.
Ohannessian A; Loundou A; Courbière B; Cravello L; Agostini A
Hum Reprod; 2014 Sep; 29(9):1949-56. PubMed ID: 25056087
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes.
Boots CE; Hill MJ; Feinberg EC; Lathi RB; Fowler SA; Jungheim ES
J Assist Reprod Genet; 2016 May; 33(5):647-656. PubMed ID: 26943917
[TBL] [Abstract][Full Text] [Related]
3. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve.
Oriol B; Barrio A; Pacheco A; Serna J; Zuzuarregui JL; Garcia-Velasco JA
Fertil Steril; 2008 Nov; 90(5):1579-82. PubMed ID: 18054933
[TBL] [Abstract][Full Text] [Related]
4. Does methotrexate administration for ectopic pregnancy after in vitro fertilization impact ovarian reserve or ovarian responsiveness?
Boots CE; Gustofson RL; Feinberg EC
Fertil Steril; 2013 Dec; 100(6):1590-3. PubMed ID: 24035728
[TBL] [Abstract][Full Text] [Related]
5. Fertility after ectopic pregnancy: the DEMETER randomized trial.
Fernandez H; Capmas P; Lucot JP; Resch B; Panel P; Bouyer J;
Hum Reprod; 2013 May; 28(5):1247-53. PubMed ID: 23482340
[TBL] [Abstract][Full Text] [Related]
6. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
[TBL] [Abstract][Full Text] [Related]
7. Effect of Methotrexate or Salpingectomy for Ectopic Pregnancy on Subsequent In Vitro Fertilization-Embryo Transfer Outcomes.
Pereira N; Gerber D; Gerber RS; Lekovich JP; Elias RT; Spandorfer SD; Rosenwaks Z
J Minim Invasive Gynecol; 2015; 22(5):870-6. PubMed ID: 25917279
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate treatment for ectopic pregnancy after assisted reproductive technology: A case-control study.
Ohannessian A; Crochet P; Courbiere B; Gnisci A; Agostini A
Gynecol Obstet Fertil; 2016 Jun; 44(6):341-4. PubMed ID: 27216957
[TBL] [Abstract][Full Text] [Related]
9. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
[TBL] [Abstract][Full Text] [Related]
11. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate vs placebo in early tubal ectopic pregnancy: a multi- centre double-blind randomised trial.
Casikar I; Lu C; Reid S; Bignardi T; Mongelli M; Morris A; Wild R; Condous G
Rev Recent Clin Trials; 2012 Aug; 7(3):238-43. PubMed ID: 22540910
[TBL] [Abstract][Full Text] [Related]
13. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
[TBL] [Abstract][Full Text] [Related]
14. Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study.
Courbiere B; Decanter C; Bringer-Deutsch S; Rives N; Mirallié S; Pech JC; De Ziegler D; Carré-Pigeon F; May-Panloup P; Sifer C; Amice V; Schweitzer T; Porcu-Buisson G; Poirot C;
Hum Reprod; 2013 Sep; 28(9):2381-8. PubMed ID: 23832792
[TBL] [Abstract][Full Text] [Related]
15. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison.
van Mello NM; Mol F; Verhoeve HR; van Wely M; Adriaanse AH; Boss EA; Dijkman AB; Bayram N; Emanuel MH; Friederich J; van der Leeuw-Harmsen L; Lips JP; Van Kessel MA; Ankum WM; van der Veen F; Mol BW; Hajenius PJ
Hum Reprod; 2013 Jan; 28(1):60-7. PubMed ID: 23081873
[TBL] [Abstract][Full Text] [Related]
17. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
[TBL] [Abstract][Full Text] [Related]
18. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
19. Ovarian response to controlled ovarian hyperstimulation: what does serum FSH say?
Oudshoorn SC; van Tilborg TC; Hamdine O; Torrance HL; Eijkemans MJC; Lentjes EGWM; Lambalk CB; Broekmans FJM
Hum Reprod; 2017 Aug; 32(8):1701-1709. PubMed ID: 28854580
[TBL] [Abstract][Full Text] [Related]
20. Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study.
Helmy S; Bader Y; Pablik E; Tiringer D; Pils S; Laml T; Kölbl H; Koch M
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():175-80. PubMed ID: 24956362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
